Medy-Tox Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	247,290	228,622	221,121	195,096	184,870
Other Revenue	-	-	-	-0	-0
Revenue	247,290	228,622	221,121	195,096	184,870
Revenue Growth (YoY)	8.17%	3.39%	13.34%	5.53%	31.27%
Cost of Revenue	104,449	90,038	87,625	69,048	79,397
Gross Profit	142,841	138,584	133,496	126,048	105,473
Selling, General & Admin	88,723	78,370	86,605	47,679	41,938
Research & Development	29,190	29,821	25,133	23,324	23,267
Amortization of Goodwill & Intangibles	2,340	2,282	1,284	799.22	834.58
Other Operating Expenses	1,413	1,346	1,322	1,242	1,216
Operating Expenses	126,163	118,236	116,173	79,383	72,335
Operating Income	16,679	20,349	17,322	46,665	33,138
Interest Expense	-649.39	-1,727	-2,333	-2,314	-4,781
Interest & Investment Income	1,395	925.15	896.43	610.76	957.22
Earnings From Equity Investments	-7,314	5,877	1,363	5,129	-1,456
Currency Exchange Gain (Loss)	-325.57	4,387	475.22	3,425	2,111
Other Non Operating Income (Expenses)	106.18	-4,138	-605.87	-715.84	108,431
EBT Excluding Unusual Items	9,891	25,673	17,118	52,800	138,400
Gain (Loss) on Sale of Investments	-4,378	126.49	-593.36	-3,044	2,666
Gain (Loss) on Sale of Assets	305.61	323.58	-671.97	-230.42	131.48
Asset Writedown	764.94	-8,624	-	-	-12,932
Pretax Income	6,583	17,499	15,853	49,526	128,265
Income Tax Expense	-9,076	1,425	6,163	12,930	35,003
Earnings From Continuing Operations	15,659	16,074	9,690	36,596	93,263
Minority Interest in Earnings	935.18	881.22	65.28	414.16	891.27
Net Income	16,594	16,955	9,755	37,010	94,154
Preferred Dividends & Other Adjustments	-	-	975	975.33	974.73
Net Income to Common	16,594	16,955	8,780	36,035	93,179
Net Income Growth	-2.13%	73.81%	-73.64%	-60.69%	-
Shares Outstanding (Basic)	7	7	7	7	6
Shares Outstanding (Diluted)	7	7	7	7	6
Shares Change (YoY)	-1.88%	6.51%	2.02%	2.28%	0.04%
EPS (Basic)	2371.00	2377.00	1311.06	5491.68	14587.59
EPS (Diluted)	2371.00	2377.00	1311.00	5489.34	14517.37
EPS Growth	-0.25%	81.31%	-76.12%	-62.19%	-
Free Cash Flow	45,749	27,830	5,862	16,304	2,452
Free Cash Flow Per Share	6536.71	3901.65	875.31	2483.66	382.01
Gross Margin	57.76%	60.62%	60.37%	64.61%	57.05%
Operating Margin	6.74%	8.90%	7.83%	23.92%	17.93%
Profit Margin	6.71%	7.42%	3.97%	18.47%	50.40%
Free Cash Flow Margin	18.50%	12.17%	2.65%	8.36%	1.33%
EBITDA	36,745	40,307	32,698	61,766	51,394
EBITDA Margin	14.86%	17.63%	14.79%	31.66%	27.80%
D&A For EBITDA	20,067	19,959	15,376	15,101	18,256
EBIT	16,679	20,349	17,322	46,665	33,138
EBIT Margin	6.74%	8.90%	7.83%	23.92%	17.93%
Effective Tax Rate	-	8.15%	38.88%	26.11%	27.29%
Advertising Expenses	6,494	7,146	5,976	3,351	2,031

Source: S&P Global Market Intelligence. Standard template. Financial Sources.